Champions Oncology (CSBR) Equity Ratio (2016 - 2026)
Champions Oncology (CSBR) has 15 years of Equity Ratio data on record, last reported at 0.14 in Q4 2025.
- For Q4 2025, Equity Ratio rose 412.41% year-over-year to 0.14; the TTM value through Oct 2025 reached 0.14, up 412.41%, while the annual FY2025 figure was 0.12, 260.14% up from the prior year.
- Equity Ratio reached 0.14 in Q4 2025 per CSBR's latest filing, up from 0.12 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.32 in Q1 2021 and bottomed at 0.08 in Q1 2024.
- Average Equity Ratio over 5 years is 0.15, with a median of 0.16 recorded in 2025.
- Peak YoY movement for Equity Ratio: plummeted 153.9% in 2024, then surged 969.84% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.28 in 2021, then fell by 8.45% to 0.25 in 2022, then tumbled by 98.7% to 0.0 in 2023, then skyrocketed by 720.86% to 0.03 in 2024, then soared by 412.41% to 0.14 in 2025.
- Per Business Quant database, its latest 3 readings for Equity Ratio were 0.14 in Q4 2025, 0.12 in Q3 2025, and 0.12 in Q2 2025.